I watched the documentary with great interest this weekend. On one hand, the stories told by and about the families of AD patients were extremely compelling and provided valuable insight into the experience of the disease and the prospect of research participation by at-risk family members, the latter being an under-studied facet of dementia research, in my view.

It was also noteworthy that the documentary did address (albeit briefly) the issue of benefits to research participants (in Colombia) at the end of the trial, e.g., access, participation in other trials, etc. This is an often overlooked aspect of trials conducted in other countries.

View all comments by Robin Pierce